Get Live Data

Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners
Tribe Technology set to deliver healthy pipeline of orders from Tier-One minersView Video
Andrada Mining acquisition elevates the miner to emerging mid-tier status
Andrada Mining acquisition elevates the miner to emerging mid-tier statusView Video

Latest Share Chat

  2. Share Prices
  3. Oxford Biomedica Share Price
  4. Oxford Biomedica Share Regulatory News
  5. Director/PDMR Shareholding

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Oxford Biomedica Information

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.50
Bid: 297.50
Ask: 300.00
Change: -6.00 (-1.98%)
Spread: 2.50 (0.84%)
Open: 313.00
High: 313.50
Low: 296.50
Prev. Close: 302.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

25 Oct 2007 11:27

Oxford Biomedica PLC25 October 2007 Oxford BioMedica plc (the "Company") Director Shareholdings Oxford, UK: Oxford BioMedica plc (LSE : OXB) announces that it has been informedthat Nick Rodgers, senior independent director of the Company, today bought10,000 1p ordinary shares (0.002% of the current issued share capital) at aprice of 33.25 pence per share. Following this purchase of shares, Nick Rodgers is the beneficial owner of52,000 1p ordinary shares representing 0.01% of the Company's current issuedshare capital. 25 October 2007 This information is provided by RNS The company news service from the London Stock Exchange
5678910111213
Date   Source Headline
23rd Apr 201811:46 amRNSDirector Dealings / Market Share Purchase
11th Apr 20182:11 pmRNSDirector Dealings / Market Share Purchase
9th Apr 20185:39 pmRNSDirector/PDMR Shareholding
9th Apr 201810:47 amRNSDirector/PDMR Shareholding
5th Apr 201812:08 pmRNSDirector/PDMR Shareholding
3rd Apr 20189:45 amRNSTotal Voting Rights
22nd Mar 201811:05 amRNSDirector/PDMR Shareholding
20th Mar 20187:15 amRNSHardman & Co Res: Supply to meet demand
15th Mar 20187:01 amRNSBoard Change
15th Mar 20187:01 amRNSPreliminary Results
9th Mar 20186:41 pmRNSResult of Placing
9th Mar 20183:42 pmRNSPROPOSED PLACING TO RAISE APPROXIMATELY £20.5M
9th Mar 20183:17 pmRNSPROPOSED PLACING TO RAISE APPROXIMATELY £20.5M
1st Mar 20189:33 amRNSTotal Voting Rights
28th Feb 20187:15 amRNSHardman & Co Res: BIVV deal establishes structure
23rd Feb 20182:03 pmRNSDirector/PDMR Shareholding
20th Feb 20182:12 pmRNSHoldings in Company
15th Feb 20187:00 amRNSBioverativ Collaboration and Licence Agreement
1st Feb 201811:28 amRNSTotal Voting Rights
23rd Jan 20189:45 amRNS£3 million Innovate UK grant
23rd Jan 20189:30 amRNSDirector Dealings / Market Share Purchase
17th Jan 20187:00 amRNSKymriah receives Priority Review for adult DLBCL
9th Jan 20189:54 amRNSBLOCK LISTING RETURN
9th Jan 20189:54 amRNSBLOCK LISTING RETURN
3rd Jan 20181:33 pmRNSHolding(s) in Company
2nd Jan 20189:49 amRNSTotal Voting Rights
20th Dec 201711:22 amRNSDirector Dealings / Market Share Purchase
11th Dec 20177:08 amRNSPrimary analysis results from JULIET trial
1st Dec 201710:16 amRNSTotal Voting Rights
23rd Nov 201711:29 amRNSDirector Dealings / Market Share Purchase
9th Nov 20177:00 amRNSOXB to present at Jefferies Healthcare Conference
6th Nov 201712:06 pmRNSHoldings in Company
6th Nov 20177:37 amRNSCTL019 MAA submission to the EMA
1st Nov 20179:19 amRNSTotal Voting Rights
31st Oct 20174:01 pmRNSKymriah submitted to FDA for adults with r/r DLBCL
23rd Oct 201711:27 amRNSDirector Dealings / Market Share Purchase
2nd Oct 201711:21 amRNSTotal Voting Rights
26th Sep 20172:55 pmRNSDirector Dealings / Market Share Purchase
26th Sep 20179:37 amRNSLong Term Incentive Plan Option Grant
25th Sep 20173:05 pmRNSBlock listing application
25th Sep 20179:46 amRNSCantor Fitzgerald Healthcare Conference 2017
22nd Sep 201712:36 pmRNSDirector Dealings
20th Sep 20173:25 pmRNSHolding(s) in Company
19th Sep 20178:58 amRNSDirector Dealings
15th Sep 20179:21 amRNSDirector/PDMR Shareholding
12th Sep 20177:15 amRNSHardman Research: New advanced therapies era
7th Sep 201710:11 amRNSHoldings in Company
5th Sep 201711:45 amRNSDirector/PDMR Shareholding
5th Sep 201711:39 amRNSDirector/PDMR Shareholding
5th Sep 20177:00 amRNSOXB to Present at Rodman & Renshaw Conference
5678910111213

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.